Show simple item record

Prevalence and burden of overactive bladder in the United States

dc.contributor.authorWein, A.en_US
dc.contributor.authorCundiff, Geoffrey W.en_US
dc.contributor.authorStewart, W. F.en_US
dc.contributor.authorHerzog, A. Regulaen_US
dc.contributor.authorVan Rooyen, J.en_US
dc.contributor.authorHunt, T.en_US
dc.contributor.authorAbrams, P.en_US
dc.contributor.authorCorey, R.en_US
dc.date.accessioned2006-09-08T20:02:43Z
dc.date.available2006-09-08T20:02:43Z
dc.date.issued2003-05en_US
dc.identifier.citationStewart, W.; Van Rooyen, J.; Cundiff, G.; Abrams, P.; Herzog, A.; Corey, R.; Hunt, T.; Wein, A.; (2003). "Prevalence and burden of overactive bladder in the United States." World Journal of Urology 20(6): 327-336. <http://hdl.handle.net/2027.42/42170>en_US
dc.identifier.issn0724-4983en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/42170
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=12811491&dopt=citationen_US
dc.description.abstractContext: the National Overactive BLadder Evaluation (NOBLE) Program was initiated to better understand the prevalence and burden of overactive bladder in a broad spectrum of the United States population. Objective: to estimate the prevalence of overactive bladder with and without urge incontinence in the US, assess variation in prevalence by sex and other factors, and measure individual burden. Design: US national telephone survey using a clinically validated interview and a follow-up nested study comparing overactive bladder cases to sex- and age-matched controls. Setting: noninstitutionalized US adult population. Participants: a sample of 5,204 adults ≥18 years of age and representative of the US population by sex, age, and geographical region. Main outcome measures: prevalence of overactive bladder with and without urge incontinence and risk factors for overactive bladder in the US. In the nested case-control study, SF-36, CES-D, and MOS sleep scores were used to assess impact. Results: the overall prevalence of overactive bladder was similar between men (16.0%) and women (16.9%), but sex-specific prevalence differed substantially by severity of symptoms. In women, prevalence of urge incontinence increased with age from 2.0% to 19% with a marked increase after 44 years of age, and in men, increased with age from 0.3% to 8.9% with a marked increase after 64 years of age. Across all age groups, overactive bladder without urge incontinence was more common in men than in women. Overactive bladder with and without urge incontinence was associated with clinically and significantly lower SF-36 quality-of-life scores, higher CES-D depression scores, and poorer quality of sleep than matched controls. Conclusions: the NOBLE studies do not support the commonly held notion that women are considerably more likely than men to have urgency-related bladder control problems. The overall prevalence of overactive bladder does not differ by sex; however, the severity and nature of symptom expression does differ. Sex-specific anatomic differences may increase the probability that overactive bladder is expressed as urge incontinence among women compared with men. Nonetheless, overactive bladder, with and without incontinence, has a clinically significant impact on quality-of-life, quality-of-sleep, and mental health, in both men and women.en_US
dc.format.extent239935 bytes
dc.format.extent3115 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherSpringer-Verlagen_US
dc.subject.otherLegacyen_US
dc.titlePrevalence and burden of overactive bladder in the United Statesen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumUniversity of Michigan, Ann Arbor, MI, USA,en_US
dc.contributor.affiliationotherDepartment of Epidemiology, Johns Hopkins University, 615 North Wolfe Street, Room 6039E,Baltimore, MD 21205, USA,en_US
dc.contributor.affiliationotherPharmacia Corporation, Peapack, NJ, USA,en_US
dc.contributor.affiliationotherDepartment of Epidemiology, Johns Hopkins University, 615 North Wolfe Street, Room 6039E,Baltimore, MD 21205, USA,en_US
dc.contributor.affiliationotherUniversity of Pennsylvania, Philadelphia, PA, USA,en_US
dc.contributor.affiliationotherBristol Urological Institute, Bristol, UK,en_US
dc.contributor.affiliationotherPharmacia Corporation, Peapack, NJ, USA,en_US
dc.contributor.affiliationotherDepartment of Epidemiology, Johns Hopkins University, 615 North Wolfe Street, Room 6039E,Baltimore, MD 21205, USA,en_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.identifier.pmid12811491en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/42170/1/s00345-002-0301-4.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1007/s00345-002-0301-4en_US
dc.identifier.sourceWorld Journal of Urologyen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.